Genetic analysis of the subjects who developed breast cancer in the NSABP P-1 Breast Cancer Prevention Trial indicates that the Gail model inefficiently identifies BRCA1 and BRCA2 mutation carriers, since only 6.6% (19/288) of that high-risk population carried such mutations [62]. This evidence concerns the gene BRCA1 and breast carcinoma.